Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of the Use of Betashot, a Medium Chain Triglyceride- Based (MCT) Food for Special Medical Purposes (FSMP) in Children and Adults With Epilepsy.

NCT02825745 is registered in ClinicalTrials.gov with Vitaflo International, Ltd as lead sponsor.

NCT NCT02825745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02825745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of the Use of Betashot, a Medium Chain Triglyceride- Based (MCT) Food for Special Medical Purposes (FSMP) in Children and Adults With Epilepsy.
Lead sponsor
Vitaflo International, Ltd
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2016
Completion date
December 31, 2019
Enrollment
77 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nervous system disorder